# Akebia Therapeutics, Inc.: Form 8-K, filed Apr 16, 2024

- Company: [Akebia Therapeutics, Inc.](/companies/akba.md) (CIK 1517022)
- Form: 8-K
- Filed: 2024-04-16
- Accepted by EDGAR: Apr 16, 2024, 07:33 ET
- Period: 2024-04-15
- Accession: 0001517022-24-000033
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1517022/000151702224000033/akba-20241504xwuxiamendment.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517022/000151702224000033/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1517022/000151702224000033/akba-20241504xwuxiamendment.htm

Filed Apr 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001517022-24-000033. Last ingested by Listed: Nov 5, 2026, 12:07 ET. No prices; not investment advice.
